Free Trial

NZD/USD moved uphill on Wednesday, even as.....>

KIWI
KIWI: NZD/USD moved uphill on Wednesday, even as its road was a bit bumpy.
Positive surprises in U.S. economic data triggered a fresh upswing in U.S.
hours, which was aided by good news on coronavirus vaccine trial performed by
Pfizer & BioNtech. As a result, NZD/USD finished the day higher.
- Per Barfoot's update released this morning, average house prices in Auckland
increased 1.4% Y/Y last month. Despite pick up in breakdown data, Barfoot said
"it is far too early to see this as an indicator that the property market will
defy forecasts and ride out of the Covid-19 pandemic unaffected".
- NZD/USD sits at $0.6479, a touch higher on the day. A rally above Jun 23 high
of $0.6533 would clear the way to the key near-term resistance, located at
$0.6584 (Jun 10 high). Bears see Jun 22 low of $0.6377 as their initial target
and a fall below there would expose the 200-DMA at $0.6329.
- Nothing much left on NZ calendar this week, which turns focus to broader
picture developments and Friday's Chinese Caixin Services/Composite PMIs.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.